Related Experiment Video
Updated: Oct 6, 2025
04:13
Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
489
Buprenorphine in safety-sensitive positions
Mia C Hazle1,2, Andrew J Saxon3,4, Kevin P Hill1,2
1Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA.
The American Journal of Drug and Alcohol Abuse
|January 14, 2022
Summary
Banning buprenorphine for safety-sensitive jobs overlooks its effectiveness for opioid use disorder (OUD). Case-by-case evaluations are needed due to lack of evidence on impairment from chronic use.
Area of Science:
- Pharmacology
- Occupational Health
- Public Health
Background:
- Buprenorphine is a crucial treatment for opioid use disorder (OUD).
- Concerns exist regarding potential impairment in safety-sensitive roles, leading to widespread bans.
- Current policies often disregard buprenorphine's unique properties and OUD treatment benefits.
Purpose of the Study:
- To examine the controversy surrounding buprenorphine use in safety-sensitive positions.
- To analyze the scientific basis for concerns about impairment.
- To advocate for individualized assessments over universal bans.
Main Methods:
- Review of existing literature on buprenorphine's pharmacological profile.
- Analysis of studies on opioid-induced impairment.
- Examination of policy implications and public health consequences.
Main Results:
- Buprenorphine is a partial mu-opioid agonist, distinct from full agonists.
- Limited evidence supports impairment from chronic buprenorphine use, especially when task-specific.
- Universal bans may increase OUD relapse and overdose risks.
Conclusions:
- Buprenorphine policies for safety-sensitive roles require careful reconsideration.
- Individualized assessments are more appropriate than blanket prohibitions.
- Policy changes could improve OUD treatment adherence and reduce harm.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
489
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
489
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
438
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
438
01:25Analgesia and Pain Management
902
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
902
01:21Drugs for Treatment of Constipation-Predominant IBS
371
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
371
01:02Prescription, Nonprescription and Orphan Drugs
886
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
886
01:14CNS Depressants: Barbiturates and Benzodiazepines
590
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
590